Home › GlaxoSmithKline Pharma loses patent claim on breast cancer drug Tykerb
 

Keywords :   


GlaxoSmithKline Pharma loses patent claim on breast cancer drug Tykerb

2013-08-02 16:15:06| Biotech - Topix.net

The Intellectual Property Appellate Board has revoked the patent granted to the British drug major Glaxosmithkline Pharma Ltd for its breast cancer drug - Tykerb.

Tags: drug claim cancer patent

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.11DX&DX
14.111973
14.11Grand Prix 5000 S TR 25C
14.11PUMA Z 1.2 FG/AG FIRST MILE
14.11.45
14.1163
14.11DVD18
14.11THEE MICHELLE GUN ELEPHANT
More »